期刊文献+

尼莫地平静脉应用和术中灌洗对预防血管痉挛作用的临床研究 被引量:11

Remission effect on vasospasm by using intravenous nimodipine infusion and rinsing with freshly solution
下载PDF
导出
摘要 目的研究尼莫地平围手术期静脉应用以及术中灌洗对动脉瘤破裂致蛛网膜下腔出血患者手术后血管痉挛预防的临床疗效。方法统计我科2005年1月至2009年2月经手术治疗的动脉瘤性蛛网膜下腔出血患者,根据围手术期是否规范使用尼莫地平以及术中是否同时进行术野内灌洗分为3组,分析其与血管痉挛发生率的相关性。结果围手术期规范使用尼莫地平患者术后血管痉挛发生率(23.2%)明显低于未规范使用该药物者(36.3%),P<0.01;术中同时进行灌洗组血管痉挛发生率最低(12.5%),灌洗组与单纯静脉用药组差异有统计学意义(P=0.042)。出现术后严重并发症的发生率静脉用药组为13.7%,同时辅助术中灌洗组为20.0%,而对照组为32.7%。结论围手术期静脉内使用尼莫地平可以有效降低术后血管痉挛的发生率,并减少患者术后严重并发症的发生比例,术中灌洗在一定程度上可以进一步增加这种抗血管痉挛的作用和效果。 Objective To study the remission effect on vasospasm by using intravenous nimodipine infusion clinically and rinsing with freshly solution during the operation. Methods The patients suffered from the subarachnoid hemorrhage and received the operation during Jan 2005 to Feb 2009 were divided into 3 groups, according to whether using intravenous nimodipine infusion clinically, and together with rinsing in operation or not. Results The incidence rate of cerebral vasospasm in intravenous group was 23.2% ,compared with the 36.3% in control group,and the statis-tical difference is positive (P〈0.01) ; the vasospasm occured in 12.5% patients in rinsing group, which was the lowest among the 3 groups,but the statistical difference is not obvious(P=0.042). The occurance of severe complications in 3 groups were 13.7% ,20.0% and 32.7% respectively. Conclusion Nimodipine is effective in reducing the incidence rate of cerebral vasospasm, and also can prevent severe complications from occuring, while this effect can be enhanced together with rinsing solution in operation.
出处 《实用药物与临床》 CAS 2009年第3期166-168,共3页 Practical Pharmacy and Clinical Remedies
基金 国家十一五科技支撑计划课题子课题(2006ba101a12)
关键词 尼莫地平 蛛网膜下腔出血 脑血管痉挛 Nimodipine Subarachnoid hemorrhage Cerebral vasospasm
  • 相关文献

参考文献9

  • 1Komotar RJ,Zacharia BE,Valhora R,et al.Advances in vasospasm treatment and prevention[J].Journal of the Neurological Sciences,2007,261(1-2):134-142.
  • 2Schmidt JM,Wartenberg KE,Fernandez A,et al.Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage[J].J Neurosurg,2008,109(6):1052-1059.
  • 3Pearl JD,Macdonald RL.Vasospasm after aneurysmal subarachnoid hemorrhage:need for further study[J].Acta Neurochir Suppl,2008,105:207-210.
  • 4Harrod CG,Bendok BR,Batjer HH,et al.Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage:a review[J].Neurosurgery,2005,56(4):633-654.
  • 5Tomassoni D,Lanari A,Silvestrelli G,et al.Nimodipine and its use in cerebrovascular disease:evidence from recent preclinical and controlled clinical studies[J].Clin Exp Hypertens,2008,30(8):744-766.
  • 6吴冰,甄勇,刘兵,杨忠熙,罗祺.尼莫地平治疗蛛网膜下腔出血120例疗效观察[J].吉林医学,2009,30(1):20-21. 被引量:11
  • 7Tomassoni D,Lanari A,Silvestrelli G,et al.Nimodipine and Its Use in Cerebrovascular Disease:Evidence from Recent Preclinical and Controlled Clinical Studies[J].Clinical and Experimental Hypertension,2008,30(8):744-766.
  • 8Hanggi D,Beseoglu K,Turowski B,et al.Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy[J].Clin Neurol Neurosurg,2008,110(8):784-790.
  • 9武琛,王硕,刘巍.颅内动脉瘤手术中尼莫地平与罂粟碱术野灌洗疗效的对照观察[J].中国现代神经疾病杂志,2004,4(6):385-386. 被引量:10

二级参考文献18

  • 1Feigin VL,Rinkel GJ. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review [ J ]. Neurology, 1998,50 (4) : 876.
  • 2Janjua N, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage[J]. Curr Opin Crit Care,2003,9(2) :113.
  • 3Biller J, Godersky JC, Adam HP Jr. Management of aneurysmal subarachnoid hemorrhage [J]. Stroke, 1998,19(10) : 1300.
  • 4Condette Atdiac S, Bracard S, Anxionnat R, et al. Vasospasm after SAH: interest in diffusion weighted MR imaging [ J ]. Stroke, 2001, 32(8) :1818.
  • 5Horky LL,Pluta RM,Boock RJ,et al. Role of ferrous iron chelator 2,2 - dipyridy.l in preventing delayed vasospasm in aprimate model of subarachnoid hemorrhage [J].J Neu Rosurg,1998,88(2):298.
  • 6Meyer FB. Calcium antagonists and vasospasm [ J ]. Neurosurg Clin N Am,1990,1(2) :367.
  • 7Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage [ J ]. Curr Opin Crit Care,2002,8 (2) : 128.
  • 8Treggiari - Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage:a problem of neurointensive care [ J ]. Neurosurgery, 2001,48(2) :249.
  • 9[5]Luer MS, Dujovny M, Slavin KV, et al. Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report. Neurosurgery, 1995,36:1033-1036.
  • 10[6]Fujiwara N, Honjo Y, Ohkawa M, et al. Effectiveness of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for symptomatic vasospasm after subarachnoid hemorrhage. Nippon Igaku Hoshasen Gakkai Zasshi, 1997, 57:412-417.

共引文献19

同被引文献101

引证文献11

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部